Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4

Molecular Cancer Therapeutics
Jay HarperAdeela Kamal

Abstract

Antibody-drug conjugates (ADC) are used to selectively deliver cytotoxic agents to tumors and have the potential for increased clinical benefit to cancer patients. 5T4 is an oncofetal antigen overexpressed on the cell surface in many carcinomas on both bulk tumor cells as well as cancer stem cells (CSC), has very limited normal tissue expression, and can internalize when bound by an antibody. An anti-5T4 antibody was identified and optimized for efficient binding and internalization in a target-specific manner, and engineered cysteines were incorporated into the molecule for site-specific conjugation. ADCs targeting 5T4 were constructed by site-specifically conjugating the antibody with payloads that possess different mechanisms of action, either a DNA cross-linking pyrrolobenzodiazepine (PBD) dimer or a microtubule-destabilizing tubulysin, so that each ADC had a drug:antibody ratio of 2. The resulting ADCs demonstrated significant target-dependent activity in vitro and in vivo; however, the ADC conjugated with a PBD payload (5T4-PBD) elicited more durable antitumor responses in vivo than the tubulysin conjugate in xenograft models. Likewise, the 5T4-PBD more potently inhibited the growth of 5T4-positive CSCs in vivo, which lik...Continue Reading

References

Nov 1, 1992·British Journal of Cancer·T StarzynskaP L Stern
Jan 15, 1990·International Journal of Cancer. Journal International Du Cancer·N Hole, P L Stern
Jan 1, 1990·British Journal of Cancer·P J SouthallP L Stern
Mar 1, 1988·British Journal of Cancer·N Hole, P L Stern
May 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·G M EdelmanM J Waxdal
May 1, 1994·British Journal of Cancer·T StarzynskaP L Stern
Sep 27, 1996·International Journal of Cancer. Journal International Du Cancer·C J CarsbergP L Stern
Sep 1, 1996·Immunotechnology : an International Journal of Immunological Engineering·J K OsbournJ McCafferty
Dec 17, 1998·European Journal of Gastroenterology & Hepatology·T StarzynskaP L Stern
Jul 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E. WrigleyP.L. Stern
Jan 19, 2002·Biochemical and Biophysical Research Communications·Abida AwanPeter L Stern
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Feb 5, 2008·Cancer Cell·Zhen Fan YangSheung Tat Fan
Nov 18, 2008·Cancer Research·Gail D Lewis PhillipsMark X Sliwkowski
Apr 5, 2011·Expert Opinion on Investigational Drugs·John A Hartley
Apr 14, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Saly Al-TaeiZsuzsanna Tabi
Nov 1, 2012·Journal of Clinical Pathology·Francisco Ferro de BeçaFernando Schmitt
Oct 8, 2013·Oncogene·S J VidalJ Domingo-Domenech
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Andrew J MurphyGeorge D Yancopoulos
Aug 5, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Minh NguyenAndrew D Simmons
Sep 1, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Boris ShorPuja Sapra
Nov 22, 2015·Pharmacological Reviews·Paul Polakis
Jan 8, 2016·British Journal of Cancer·Nikolaos Diamantis, Udai Banerji
Mar 11, 2016·Current Opinion in Immunology·Bart Ecg de Goeij, John M Lambert
Jun 22, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pamela ThompsonNazzareno Dimasi
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Samuel A KerkJacques E Nör
Nov 5, 2016·Journal of Medicinal Chemistry·Dorin ToaderAdeela Kamal
Nov 25, 2016·ACS Medicinal Chemistry Letters·Arnaud C TiberghienPhilip W Howard

❮ Previous
Next ❯

Citations

May 24, 2019·PLoS Neglected Tropical Diseases·Paula MacGregorMark Carrington
Jun 17, 2020·Expert Opinion on Biological Therapy·John A Hartley
Apr 16, 2019·Frontiers in Oncology·Fabrizio MarcucciCristiano Rumio
Aug 23, 2018·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Eshita Khera, Greg M Thurber
Feb 6, 2019·Therapeutic Advances in Vaccines and Immunotherapy·Richard HarropPeter L Stern
Dec 9, 2020·Chemical Society Reviews·Stephen J WalshDavid R Spring
Jun 6, 2018·Molecular Cancer Therapeutics·Patrick J BurkeScott C Jeffrey
Jan 2, 2021·Blood Reviews·Joshua Richter, Santiago Thibaud
Mar 27, 2019·Bioconjugate Chemistry·Qing LiM Jack Borrok

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.